Javitt; Daniel

Patent Applications and Registrations

Patent applications and USPTO patent grants for Javitt; Daniel.The latest application filed is for "system, method and computer-accessible medium for predicting response to electroconvulsice therapy based on brain functional con".

Company Profile

3.7.15

Javitt; Daniel - Fort Lee NJ
Javitt; Daniel - Bardonia NY
Javitt; Daniel - Wilmington DE
JAVITT; DANIEL - Ft. Lee NJ
Javitt, Daniel - Riverdale NY

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
System, method and computer-accessible medium for predicting response to electroconvulsive therapy based on brain functional connectivity patterns Grant 11,331,041 - Javitt , et al. May 17, 2	2022-05-17
System, method and computer-accessible medium for predicting response to electroconvulsive therapy based on brain functional connectivity patterns Grant 11,311,193 - Javitt , et al. April 26, 2	2022-04-26
Dosage regimen, medication dispensing package and uses thereof for the treatment of major depressive disorder Grant 11,013,721 - Heresco-Levy , et al. May 25, 2	2021-05-25
System, Method And Computer-accessible Medium For Predicting Response To Electroconvulsice Therapy Based On Brain Functional Con App 20200275838 - JAVITT; DANIEL ; et al.	2020-09-03
System, Method And Computer-accessible Medium For Determining Possibility/likelihood Of Mental Disorder App 20200178834 - JAVITT; Daniel ; et al.	2020-06-11
System, Method And Computer-accessible Medium For Predicting Response To Electroconvulsive Therapy Based On Brain Functional Con App 20200107777 - Javitt; Daniel ; et al.	2020-04-09
Dosage Regimen, Medication Dispensing Package and Uses Thereof for the Treatment of Major Depressive Disorder App 20200038375 - HERESCO-LEVY; Uriel ; et al.	2020-02-06
Pharmaceutical Compositions And Methods Utilizing A D-amino Acid App 20190240169 - Javitt; Daniel	2019-08-08
Pharmaceutical compositions and methods utilizing a D-amino acid Grant 10,265,278 - Javitt	2019-04-23
Dosage Regimen, Medication Dispensing Package and Uses Thereof for the Treatment of Major Depressive Disorder App 20180092881 - HERESCO-LEVY; URIEL ; et al.	2018-04-05
Dosage Regimen, Medication Dispensing Package and Uses Thereof for the Treatment of Major Depressive Disorder App 20180028503 - HERESCO-LEVY; Uriel ; et al.	2018-02-01
Dosage Regimen, Medication Dispensing Package and Uses Thereof for the Treatment of Major Depressive Disorder App 20180028504 - HERESCO-LEVY; Uriel ; et al.	2018-02-01
Dosage regimen, medication dispensing package and uses thereof for the treatment of major depressive disorder Grant 9,789,093 - Heresco-Levy , et al. October 17, 2	2017-10-17
Pharmaceutical Compositions And Methods Utilizing A D-amino Acid App 20170157066 - Javitt; Daniel	2017-06-08
Dosage Regimen, Medication Dispensing Package and Uses Thereof for the Treatment of Major Depressive Disorder App 20140018349 - Heresco-Levy; Uriel ; et al.	2014-01-16
Pharmaceutical Compositions and Methods Utilizing a D-Amino Acid App 20090176715 - Javitt; Daniel	2009-07-09
D-serine transport antagonist for treating psychosis App 20050159488 - Javitt, Daniel	2005-07-21
D-serine transport antagonist for treating psychosis App 20020183390 - Javitt, Daniel	2002-12-05
Treatment of negative and cognitive symptoms of schizophrenia with D-serine Grant 6,162,827 - Javitt December 19, 2	2000-12-19

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.